Singh B, Nayak B P, Rao K V, Sharma P
Immunology Group, International Centre for Genetic Engineering & Biotechnology, New Delhi, Aruna Asaf Ali Marg, India.
Microbes Infect. 2000 Apr;2(5):473-80. doi: 10.1016/s1286-4579(00)00321-x.
The rodent malaria parasite, Plasmodium yoelii nigeriensis is known to cause fatal malaria infections in BALB/c mice. However, we found that nearly 5% of inbred BALB/c mice could overcome primary infections initiated with lethal inoculum of P. y. nigeriensis asexual blood-stages, without any experimental intervention. These 'survivor' mice developed peak parasitemia levels of about 5% and successfully resolved their infections in about two weeks time; infected blood collected during the descending phase of infection in these mice and subinoculated in naive recipients resulted in a normal lethal course of infection. Typically, the parasites in survivor mice looked 'sick' compared to those in the susceptible mice. In experiments to define temporal basis of this protection, we found that purified splenic B cells isolated from such a survivor mouse, plus T cells from an infected or naive mouse, could adoptively transfer this protection to an X-irradiated, naive mouse against a lethal parasite challenge. Purified T cells or B cells alone from the survivor mouse donor provided no protection to the X-irradiated, naive recipient. Passive transfer of sera collected from survivor mice animals a week after recovery from infection was also able to substantially alter the course of preestablished P. y. nigeriensis infection. These findings are discussed in the light of recent reports on the genetic control of blood parasitemia in mouse malaria models. In the generally lethal malaria infections such as those caused by P. y. nigeriensis in mice and by Plasmodium falciparum in naive children, it is not clear what constitutes a protective immune response in cases which survive primary infections without any experimental or therapeutic intervention. An understanding of these mechanisms and their regulation would help design better vaccination strategies.
啮齿动物疟原虫约氏疟原虫尼氏亚种已知可在BALB/c小鼠中引发致命的疟疾感染。然而,我们发现近5%的近交BALB/c小鼠能够在没有任何实验干预的情况下,克服由约氏疟原虫尼氏亚种无性血液阶段的致死接种物引发的初次感染。这些“存活”小鼠的寄生虫血症峰值水平约为5%,并在大约两周内成功清除感染;在这些小鼠感染下降阶段采集的感染血液接种到未感染的受体小鼠中,导致了正常的致死性感染过程。通常,与易感小鼠中的寄生虫相比,存活小鼠中的寄生虫看起来“病态”。在确定这种保护的时间基础的实验中,我们发现从这样一只存活小鼠中分离出的纯化脾B细胞,加上来自感染或未感染小鼠的T细胞,能够将这种保护过继转移给经X射线照射的未感染小鼠,使其免受致命的寄生虫攻击。仅来自存活小鼠供体的纯化T细胞或B细胞对经X射线照射的未感染受体没有提供保护。从感染恢复一周后从存活小鼠收集的血清的被动转移也能够显著改变预先建立的约氏疟原虫尼氏亚种感染的进程。根据最近关于小鼠疟疾模型中血液寄生虫血症的遗传控制的报告,对这些发现进行了讨论。在通常致命的疟疾感染中,如小鼠中由约氏疟原虫尼氏亚种引起的感染以及未感染儿童中由恶性疟原虫引起的感染,在没有任何实验或治疗干预的情况下在初次感染中存活的病例中,尚不清楚什么构成保护性免疫反应。对这些机制及其调节的理解将有助于设计更好的疫苗接种策略。